Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Medicina (Kaunas, Lithuania)
|
September 29, 2019
Pulmonary Embolism and Severe Asthma: Case Report and Literature Review
Po-Hsin Lee, Pin-Kuei Fu
Respirology Case Reports
|
April 9, 2019
A 27-year-old female presented with diffuse alveolar haemorrhage due to breast angiosarcoma with lung metastasis
Po-Hsin Lee, Yun-An Chen, Pin-Kuei Fu
ACS Omega
|
June 23, 2025
Polysaccharide-Encapsulated Lauraceae Extract Complex Coating Conferring Antimicrobial Properties to Polypropylene Surfaces
Tuyet-Nhi Do, Po-Hsin Lee, Tsung-Lin Tsai, et al.
Journal of Clinical Medicine
|
June 2, 2021
Prognostic Factors to Predict ICU Mortality in Patients with Severe ARDS Who Received Early and Prolonged Prone Positioning Therapy
Po-Hsin Lee, Chen-Tsung Kuo, Chiann-Yi Hsu, et al.
Infection and Drug Resistance
|
January 30, 2023
Diagnosis of Legionnaires' Disease Assisted by Next-Generation Sequencing in a Patient with COVID-19
Po-Hsiu Huang, Yao-Ting Huang, Po-Hsin Lee, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination
Po-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang, et al.
Anti-Cancer Drugs
|
July 7, 2021
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients
Po-Hsin Lee, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.
Targeted Oncology
|
June 8, 2026
Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Anti-Cancer Drugs
|
August 7, 2025
Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR-mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors
Po-Hsin Lee, Yi-Chun Hsiao, Yen-Hsiang Huang, et al.
Medicina (Kaunas, Lithuania)
|
July 27, 2022
Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced <i>EGFR</i>-Mutant Lung Adenocarcinoma
Po-Hsin Lee, Yen-Hsiang Huang, Ho Lin, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Medicina (Kaunas, Lithuania)
|
September 29, 2019
Pulmonary Embolism and Severe Asthma: Case Report and Literature Review
Po-Hsin Lee, Pin-Kuei Fu
Respirology Case Reports
|
April 9, 2019
A 27-year-old female presented with diffuse alveolar haemorrhage due to breast angiosarcoma with lung metastasis
Po-Hsin Lee, Yun-An Chen, Pin-Kuei Fu
ACS Omega
|
June 23, 2025
Polysaccharide-Encapsulated Lauraceae Extract Complex Coating Conferring Antimicrobial Properties to Polypropylene Surfaces
Tuyet-Nhi Do, Po-Hsin Lee, Tsung-Lin Tsai, et al.
Journal of Clinical Medicine
|
June 2, 2021
Prognostic Factors to Predict ICU Mortality in Patients with Severe ARDS Who Received Early and Prolonged Prone Positioning Therapy
Po-Hsin Lee, Chen-Tsung Kuo, Chiann-Yi Hsu, et al.
Infection and Drug Resistance
|
January 30, 2023
Diagnosis of Legionnaires' Disease Assisted by Next-Generation Sequencing in a Patient with COVID-19
Po-Hsiu Huang, Yao-Ting Huang, Po-Hsin Lee, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination
Po-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang, et al.
Anti-Cancer Drugs
|
July 7, 2021
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients
Po-Hsin Lee, Kun-Chieh Chen, Kuo-Hsuan Hsu, et al.
Targeted Oncology
|
June 8, 2026
Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Anti-Cancer Drugs
|
August 7, 2025
Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR-mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors
Po-Hsin Lee, Yi-Chun Hsiao, Yen-Hsiang Huang, et al.
Medicina (Kaunas, Lithuania)
|
July 27, 2022
Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced <i>EGFR</i>-Mutant Lung Adenocarcinoma
Po-Hsin Lee, Yen-Hsiang Huang, Ho Lin, et al.
Page
of 3